{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:43:06Z","timestamp":1792082586742,"version":"4.4.0"},"reference-count":16,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2018.4196","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T18:00:25Z","timestamp":1541527225000},"page":"e184196","source":"Crossref","is-referenced-by-count":38,"title":["Assessment of Patient Medication Adherence, Medical Record Accuracy, and Medication Blood Concentrations for Prescription and Over-the-Counter Medications"],"prefix":"10.1001","volume":"1","author":[{"given":"Jeffrey J.","family":"Sutherland","sequence":"first","affiliation":[{"name":"Precera Bioscience, Franklin, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Morrison","sequence":"additional","affiliation":[{"name":"Precera Bioscience, Franklin, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace D.","family":"McNaughton","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Daly","sequence":"additional","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Milne","sequence":"additional","affiliation":[{"name":"Precera Bioscience, Franklin, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Scott","family":"Daniels","sequence":"additional","affiliation":[{"name":"Precera Bioscience, Franklin, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Ryan","sequence":"additional","affiliation":[{"name":"Precera Bioscience, Franklin, Tennessee"},{"name":"now with Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"issue":"6","key":"zoi180188r1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"zoi180188r3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3810\/pgm.2013.07.2684","article-title":"Risks, management, and monitoring of combination opioid, benzodiazepines, and\/or alcohol use.","volume":"125","author":"Gudin","year":"2013","journal-title":"Postgrad Med"},{"issue":"8","key":"zoi180188r4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00228-010-0857-7","article-title":"Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.","volume":"66","author":"Gervasini","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"zoi180188r5","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1177\/0091270006293754","article-title":"Therapeutic drug monitoring of antidepressants and cytochrome p450 genotyping in general practice.","volume":"46","author":"Kootstra-Ros","year":"2006","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"zoi180188r7","doi-asserted-by":"publisher","first-page":"e0185471","DOI":"10.1371\/journal.pone.0185471","article-title":"Medication adherence, medical record accuracy, and medication exposure in real-world patients using comprehensive medication monitoring.","volume":"12","author":"Ryan","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"zoi180188r8","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1021\/acschemneuro.7b00209","article-title":"Managing psychotropic medications in complex, real-world patients using comprehensive therapeutic drug monitoring.","volume":"8","author":"Sutherland","year":"2017","journal-title":"ACS Chem Neurosci"},{"issue":"24","key":"zoi180188r10","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1001\/jama.2016.16885","article-title":"US spending on personal health care and public health, 1996-2013.","volume":"316","author":"Dieleman","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"zoi180188r11","doi-asserted-by":"publisher","first-page":"e0118991","DOI":"10.1371\/journal.pone.0118991","article-title":"Co-prescription trends in a large cohort of subjects predict substantial drug-drug interactions.","volume":"10","author":"Sutherland","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"zoi180188r12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1021\/acschemneuro.7b00375","article-title":"Medication exposure in highly adherent psychiatry patients.","volume":"9","author":"Sutherland","year":"2018","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"zoi180188r13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/HYPERTENSIONAHA.117.09659","article-title":"Systolic blood pressure and biochemical assessment of adherence: a cross-sectional analysis in the emergency department.","volume":"70","author":"McNaughton","year":"2017","journal-title":"Hypertension"},{"issue":"3","key":"zoi180188r15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jama.287.3.337","article-title":"Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey.","volume":"287","author":"Kaufman","year":"2002","journal-title":"JAMA"},{"issue":"24","key":"zoi180188r16","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1001\/jama.2008.892","article-title":"Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States.","volume":"300","author":"Qato","year":"2008","journal-title":"JAMA"},{"key":"zoi180188r6","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-385467-4.00001-4","volume-title":"Therapeutic Drug Monitoring: Newer Drugs and Biomarkers","author":"Dasgupta","year":"2012"},{"key":"zoi180188r9","volume-title":"Avoidable Costs in US Healthcare: The $200 Billion Opportunity From Using Medicines More Responsibly","author":"Aitken","year":"2013"},{"key":"zoi180188r14","volume-title":"The Use of Medicines in the United States: Review of 2011","author":"Kleinrock","year":"2012"},{"key":"zoi180188r2","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Guidance for industry: providing clinical evidence of effectiveness for human drugs and biological products. https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM072008.pdf. Published May 1998. Accessed March 28, 2018."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/1\/7\/e184196\/17295081\/sutherland_2018_oi_180188.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T17:24:19Z","timestamp":1550165059000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2018.4196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,11,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.4196","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,2]]}}}